{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:13:01Z","timestamp":1792411981532,"version":"4.4.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although sarcopenia is associated with an increased risk of chronic kidney disease (CKD), its potential associations with subsequent comorbidities among patients with CKD remain unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This prospective study included 19,502 participants with CKD, defined as an estimated glomerular filtration rate less than 60\u202fmL\/min\/1.73\u202fm\n                      <jats:sup>2<\/jats:sup>\n                      . Sarcopenia is characterized according to muscle strength, muscle mass, and physical performance; low muscle strength, commonly measured using handgrip strength, is considered the most important indicator. The study outcome was post-CKD comorbidity. Multivariable Cox proportional hazards models were used to analyze the effect of sarcopenia on comorbidities. Population attributable fractions (PAFs) and potential impact fractions (PIFs) were used to quantify the population-level burden and potential benefit of improving handgrip strength.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median follow-up of 10.6\u202fyears, 5,374 participants developed one comorbidity, 2,972 developed two comorbidities, and 2,434 developed three or more comorbidities. Sarcopenia was associated with a graded increase in multimorbidity risk (approximately 12, 24, and 33% higher for one, two, and three or more comorbidities, respectively, versus non-sarcopenia). Lower handgrip strength exhibited a clear exposure\u2013response, and the lowest tertiles was associated with the greatest risk across outcomes. Among individual comorbid diseases, the strongest association was observed with osteoporosis. PAFs indicated that 5.21, 13.72, and 23.46% of cases involving one, two, or three or more comorbidities, respectively, were attributable to sarcopenia. Analysis of PIFs indicated that improving handgrip strength throughout the population (i.e., shifting lower to higher tertiles) could reduce the burden of one, two, and three or more comorbidities by approximately 12, 16, and 22%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results indicate that sarcopenia, especially low handgrip strength, increases the risk of developing comorbidities, particularly osteoporosis, among patients with CKD. Quantification of PAFs and PIFs underscores the clinical and public health potential of muscle strength assessment and strength-preserving interventions to mitigate the CKD-associated comorbidity burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1672639","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T05:17:12Z","timestamp":1765862232000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Sarcopenia associated with increased risk of comorbidities among individuals with chronic kidney disease: insights from a prospective cohort"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuanyi","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifu","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenfang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhe","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","article-title":"Chronic kidney disease","volume":"398","author":"Kalantar-Zadeh","year":"2021","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jama.2010.39","article-title":"Relation between kidney function, proteinuria, and adverse outcomes","volume":"303","author":"Hemmelgarn","year":"2010","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.2215\/CJN.12480720","article-title":"Provider perception of frailty is associated with dialysis decision making in patients with advanced CKD","volume":"16","author":"Brar","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/jcm7120493","article-title":"The number of comorbidities predicts renal outcomes in patients with stage 3\u22125 chronic kidney disease","volume":"7","author":"Lee","year":"2018","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/ki.2015.228","article-title":"Comorbidity as a driver of adverse outcomes in people with chronic kidney disease","volume":"88","author":"Tonelli","year":"2015","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.2215\/CJN.02140214","article-title":"Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States","volume":"9","author":"Sharma","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/jcsm.13425","article-title":"Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta-analysis","volume":"15","author":"Duarte","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.3390\/nu14194077","article-title":"Prevalence of sarcopenia and its impact on cardiovascular events and mortality among dialysis patients: a systematic review and meta-analysis","volume":"14","author":"Wathanavasin","year":"2022","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/jcsm.12705","article-title":"Association of sarcopenia with mortality and end-stage renal disease in those with chronic kidney disease: a UK biobank study","volume":"12","author":"Wilkinson","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e13787","DOI":"10.1002\/jcsm.13787","article-title":"Osteosarcopenia in chronic kidney disease: an overlooked syndrome?","volume":"16","author":"Caldiroli","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/jcsm.12839","article-title":"Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?","volume":"12","author":"Gungor","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"8474","DOI":"10.3390\/ijms25158474","article-title":"Pathogenesis of sarcopenia in chronic kidney disease-the role of inflammation, metabolic dysregulation, gut dysbiosis, and microRNA","volume":"25","author":"Bakinowska","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/jcsm.12757","article-title":"Association of sarcopenia with incident osteoporosis: a prospective study of 168,682 UK biobank participants","volume":"12","author":"Petermann-Rocha","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejim.2021.06.031","article-title":"Prognostic interplay of kidney function with sarcopenia, anemia, disability and cognitive impairment. The GLISTEN study","volume":"93","author":"Soraci","year":"2021","journal-title":"Eur J Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e46870","DOI":"10.7759\/cureus.46870","article-title":"Association between sarcopenia and chronic renal failure (overt and concealed) in chronic obstructive pulmonary disease (COPD) patients: a cross-sectional study","volume":"15","author":"Yogesh","year":"2023","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12877-022-02916-9","article-title":"Diabetes, sarcopenia and chronic kidney disease; the screening for CKD among older people across Europe (SCOPE) study","volume":"22","author":"Formiga","year":"2022","journal-title":"BMC Geriatr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(12)60404-8","article-title":"What makes UK biobank special?","volume":"379","author":"Collins","year":"2012","journal-title":"Lancet Lond Engl"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12916-019-1339-0","article-title":"Physical activity, multimorbidity, and life expectancy: a UK biobank longitudinal study","volume":"17","author":"Chudasama","year":"2019","journal-title":"BMC Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1161\/CIR.0000000000000601","article-title":"Systematic review for the 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"138","author":"Reboussin","year":"2018","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e2033953","DOI":"10.1001\/jamanetworkopen.2020.33953","article-title":"Temporal trends in incidence rates of lower extremity amputation and associated risk factors among patients using veterans health administration services from 2008 to 2018","volume":"4","author":"Cai","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12055-020-01108-7","article-title":"Survival analysis-part 2: cox proportional hazards model","volume":"37","author":"Deo","year":"2021","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.clnu.2022.03.025","article-title":"Association between sarcopenia and clinical outcomes in chronic kidney disease patients: a systematic review and meta-analysis","volume":"41","author":"Ribeiro","year":"2022","journal-title":"Clin Nutr Edinb Scotl"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/oem.2004.013136","article-title":"Smoothing in occupational cohort studies: an illustration based on penalised splines","volume":"61","author":"Eisen","year":"2004","journal-title":"Occup Environ Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1002\/jcsm.12857","article-title":"Handgrip strength and all-cause dementia incidence and mortality: findings from the UK biobank prospective cohort study","volume":"13","author":"Esteban-Cornejo","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/jech.2009.090274","article-title":"Categorical versus continuous risk factors and the calculation of potential impact fractions","volume":"64","author":"Barendregt","year":"2010","journal-title":"J Epidemiol Community Health"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"k757","DOI":"10.1136\/bmj.k757","article-title":"Population attributable fraction","volume":"360","author":"Mansournia","year":"2018","journal-title":"BMJ"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jcsm.12503","article-title":"Sarcopenia, long-term conditions, and multimorbidity: Findings from UK biobank participants","volume":"11","author":"Dodds","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e0262572","DOI":"10.1371\/journal.pone.0262572","article-title":"Sarcopenia and risk of osteoporosis, falls and bone fractures in patients with chronic kidney disease: a systematic review","volume":"17","author":"Rashid","year":"2022","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1210\/jc.2013-3764","article-title":"The combination of vitamin D deficiency and mild to moderate chronic kidney disease is associated with low bone mineral density and deteriorated femoral microarchitecture: results from the KNHANES 2008-2011","volume":"99","author":"Lee","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s00198-014-2745-y","article-title":"Early-stage chronic kidney disease, insulin resistance, and osteoporosis as risk factors of sarcopenia in aged population: the fourth Korea National Health and nutrition examination survey (KNHANES IV), 2008-2009","volume":"25","author":"Kim","year":"2014","journal-title":"Osteoporos Int"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"106355","DOI":"10.1016\/j.isci.2023.106355","article-title":"Phosphate depletion in insulin-insensitive skeletal muscle drives AMPD activation and sarcopenia in chronic kidney disease","volume":"26","author":"Andres-Hernando","year":"2023","journal-title":"Iscience"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2147\/CIA.S132940","article-title":"Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis","volume":"12","author":"Steffl","year":"2017","journal-title":"Clin Interv Aging"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/ndt\/gfz235","article-title":"Prevalence and correlates of physical activity across kidney disease stages: an observational multicentre study","volume":"36","author":"Wilkinson","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.mayocp.2019.12.032","article-title":"Grip strength and walking pace and cardiovascular disease risk prediction in 406,834 UK biobank participants","volume":"95","author":"Welsh","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.2337\/dc17-0921","article-title":"Associations between diabetes and both cardiovascular disease and all-cause mortality are modified by grip strength: Evidence from UK biobank, a prospective population-based cohort study","volume":"40","author":"Celis-Morales","year":"2017","journal-title":"Diabetes Care"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41370-023-00587-1","article-title":"Ambient air pollution, genetic risk and telomere length in UK biobank","volume":"34","author":"Tang","year":"2024","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1672639\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T05:17:12Z","timestamp":1765862232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1672639\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":42,"alternative-id":["10.3389\/fpubh.2025.1672639"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1672639","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"article-number":"1672639"}}